首页 > 最新文献

CVIR Endovascular最新文献

英文 中文
The contemporary management of parastomal varices by interventional radiology: a systematic review. 当代介入放射治疗造口旁静脉曲张的系统回顾。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-13 DOI: 10.1186/s42155-025-00615-1
Jack M Bell, Hugo C Temperley, Benjamin M Mac Curtain, Nicholas A Clausen, Robert S Doyle, Noel E Donlon, Kevin Sheahan, Michael J Lee

Background: Parastomal varices are a rare but serious complication in patients with portal hypertension, characterised by bleeding that can be life-threatening in a predominantly comorbid population. Traditional surgical approaches to managing parastomal varices are associated with high morbidity and recurrence rates, prompting increased interest in minimally invasive techniques. This systematic review aims to evaluate the efficacy and safety of interventional radiology (IR) procedures, including transjugular intrahepatic portosystemic shunt (TIPS), sclerotherapy and embolisation, in managing parastomal varices.

Methods: A comprehensive literature search was conducted across multiple databases, including MEDLINE, EMBASE and Web of Science, to identify studies published up to January 2025 that reported IR interventions for parastomal varices. Data were extracted on patient demographics, procedural success, recurrence rates and complications. A pooled proportions meta-analysis was performed.

Results: Five studies, encompassing 45 patients, met the inclusion criteria. The pooled technical success rate of IR procedures was 91.3%, with a clinical success rate of 80.5% over a mean follow-up of 618.4 days. The pooled mean proportion of rebleeding, predominantly minor and non-life-threatening, was 36.4%. TIPS showed the highest efficacy, but is traditionally associated with increased procedural risks compared to other interventional radiology methods.

Conclusion: IR offers a highly effective and safe alternative to traditional surgical management for parastomal varices in contemporary terms. The low recurrence and complication rates highlight the potential of IR ab initio as a first-line treatment; consequently, we advocate for its use, particularly in patients unsuitable for surgery in the minimally invasive era.

Systematic review registration: PROSPERO CRD42024627470.

背景:造口旁静脉曲张是门静脉高压患者的一种罕见但严重的并发症,其特征是出血,在主要合并症人群中可危及生命。传统的手术方法治疗造口旁静脉曲张具有较高的发病率和复发率,这促使人们对微创技术的兴趣增加。本系统综述旨在评估介入放射学(IR)治疗的有效性和安全性,包括经颈静脉肝内门静脉系统分流术(TIPS)、硬化治疗和栓塞治疗吻合口旁静脉曲张。方法:对多个数据库(包括MEDLINE、EMBASE和Web of Science)进行全面的文献检索,以确定截至2025年1月发表的关于口旁静脉曲张IR干预的研究。提取患者人口统计学、手术成功率、复发率和并发症的数据。进行合并比例荟萃分析。结果:5项研究,包括45例患者,符合纳入标准。IR手术的总技术成功率为91.3%,临床成功率为80.5%,平均随访618.4天。再出血的合并平均比例为36.4%,主要是轻微的和不危及生命的。TIPS显示出最高的疗效,但与其他介入放射学方法相比,传统上与手术风险增加有关。结论:相对于传统手术治疗造口旁静脉曲张,IR是一种高效、安全的治疗方法。低复发率和并发症率突出了从头开始IR作为一线治疗的潜力;因此,我们提倡使用它,特别是在微创时代不适合手术的患者。系统评价注册:PROSPERO CRD42024627470。
{"title":"The contemporary management of parastomal varices by interventional radiology: a systematic review.","authors":"Jack M Bell, Hugo C Temperley, Benjamin M Mac Curtain, Nicholas A Clausen, Robert S Doyle, Noel E Donlon, Kevin Sheahan, Michael J Lee","doi":"10.1186/s42155-025-00615-1","DOIUrl":"10.1186/s42155-025-00615-1","url":null,"abstract":"<p><strong>Background: </strong>Parastomal varices are a rare but serious complication in patients with portal hypertension, characterised by bleeding that can be life-threatening in a predominantly comorbid population. Traditional surgical approaches to managing parastomal varices are associated with high morbidity and recurrence rates, prompting increased interest in minimally invasive techniques. This systematic review aims to evaluate the efficacy and safety of interventional radiology (IR) procedures, including transjugular intrahepatic portosystemic shunt (TIPS), sclerotherapy and embolisation, in managing parastomal varices.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted across multiple databases, including MEDLINE, EMBASE and Web of Science, to identify studies published up to January 2025 that reported IR interventions for parastomal varices. Data were extracted on patient demographics, procedural success, recurrence rates and complications. A pooled proportions meta-analysis was performed.</p><p><strong>Results: </strong>Five studies, encompassing 45 patients, met the inclusion criteria. The pooled technical success rate of IR procedures was 91.3%, with a clinical success rate of 80.5% over a mean follow-up of 618.4 days. The pooled mean proportion of rebleeding, predominantly minor and non-life-threatening, was 36.4%. TIPS showed the highest efficacy, but is traditionally associated with increased procedural risks compared to other interventional radiology methods.</p><p><strong>Conclusion: </strong>IR offers a highly effective and safe alternative to traditional surgical management for parastomal varices in contemporary terms. The low recurrence and complication rates highlight the potential of IR ab initio as a first-line treatment; consequently, we advocate for its use, particularly in patients unsuitable for surgery in the minimally invasive era.</p><p><strong>Systematic review registration: </strong>PROSPERO CRD42024627470.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"101"},"PeriodicalIF":1.5,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12615892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145508054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver pseudoaneurysm mimicking haemangioma: a multimodal imaging trap and embolization pitfall. 肝假性动脉瘤模拟血管瘤:一个多模式成像陷阱和栓塞陷阱。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-08 DOI: 10.1186/s42155-025-00613-3
Mohamed Mostafa Fouad, Gaetan Davout, Aya E Ahmed, Alexis Quirantes, Norhane Chadli, Olivier Chevallier, Romaric Loffroy

Background: Hepatic artery pseudoaneurysms (HAP) and hepatic haemangiomas (HH) may present with indistinguishable imaging characteristics, particularly when clinical history favors one diagnosis over the other. Primary imaging alone may be insufficient for definitive differentiation. This case highlights the importance of further non-invasive imaging modalities in avoiding unnecessary invasive procedures if clinical condition allows.

Case presentation: A 55-year-old patient presented with abdominal trauma after a fall. Computed tomography (CT) revealed a grade III liver laceration with a hyper vascular lesion near the right hepatic artery, initially suspected to be a HAP. Trans-arterial embolization (TAE) was planned, and selective catheterization was performed. However, angiography showed no pseudoaneurysm filling but rather features suggestive of a haemangioma, leading to the abortion of the procedure. Subsequent magnetic resonance imaging (MRI) confirmed a flash-filling HH. The patient remained stable, with no haemorrhagic complications or need for further intervention.

Conclusion: In emergencies, recognizing imaging features distinguishing haemangiomas from pseudoaneurysms is crucial to avoid unnecessary invasive procedures, especially in stable patients, using accurate non-invasive tools like CT or MRI.

背景:肝动脉假性动脉瘤(HAP)和肝血管瘤(HH)可能表现出难以区分的影像学特征,特别是当临床病史倾向于一种诊断时。单纯的初级影像可能不足以进行明确的鉴别。这个病例强调了在临床条件允许的情况下,进一步的非侵入性成像方式在避免不必要的侵入性手术中的重要性。病例介绍:一位55岁的病人在跌倒后出现腹部创伤。计算机断层扫描(CT)显示III级肝脏撕裂伤,右肝动脉附近有高血管病变,最初怀疑是HAP。计划行经动脉栓塞术(TAE),选择性置管。然而,血管造影显示没有假性动脉瘤填充,而是血管瘤的特征,导致手术流产。随后的磁共振成像(MRI)证实了一个闪充HH。患者保持稳定,无出血性并发症或需要进一步干预。结论:在紧急情况下,识别血管瘤和假性动脉瘤的影像学特征对于避免不必要的侵入性手术至关重要,特别是在病情稳定的患者中,使用准确的非侵入性工具,如CT或MRI。
{"title":"Liver pseudoaneurysm mimicking haemangioma: a multimodal imaging trap and embolization pitfall.","authors":"Mohamed Mostafa Fouad, Gaetan Davout, Aya E Ahmed, Alexis Quirantes, Norhane Chadli, Olivier Chevallier, Romaric Loffroy","doi":"10.1186/s42155-025-00613-3","DOIUrl":"10.1186/s42155-025-00613-3","url":null,"abstract":"<p><strong>Background: </strong>Hepatic artery pseudoaneurysms (HAP) and hepatic haemangiomas (HH) may present with indistinguishable imaging characteristics, particularly when clinical history favors one diagnosis over the other. Primary imaging alone may be insufficient for definitive differentiation. This case highlights the importance of further non-invasive imaging modalities in avoiding unnecessary invasive procedures if clinical condition allows.</p><p><strong>Case presentation: </strong>A 55-year-old patient presented with abdominal trauma after a fall. Computed tomography (CT) revealed a grade III liver laceration with a hyper vascular lesion near the right hepatic artery, initially suspected to be a HAP. Trans-arterial embolization (TAE) was planned, and selective catheterization was performed. However, angiography showed no pseudoaneurysm filling but rather features suggestive of a haemangioma, leading to the abortion of the procedure. Subsequent magnetic resonance imaging (MRI) confirmed a flash-filling HH. The patient remained stable, with no haemorrhagic complications or need for further intervention.</p><p><strong>Conclusion: </strong>In emergencies, recognizing imaging features distinguishing haemangiomas from pseudoaneurysms is crucial to avoid unnecessary invasive procedures, especially in stable patients, using accurate non-invasive tools like CT or MRI.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"100"},"PeriodicalIF":1.5,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12596232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Professional fulfillment in interventional radiology. 介入放射学专业成就。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-08 DOI: 10.1186/s42155-025-00588-1
Lindsay Eysenbach, Mark Loper, Gabe Li, David S Shin, Eric J Monroe, Matthew Abad-Santos, Eunjee Lee, Hyeonjeong Lim, Anthony Hage, Jeffrey Forris Beecham Chick, Mina S Makary

Background: There have been several analyses conducted demonstrating a sharp decrease in general physician fulfillment and satisfaction. Other studies have demonstrated that burnout, anxiety, and moral injury are prevalent among interventional radiologists specifically, however there is a paucity of literature examining professional fulfillment within the profession. The purpose of this study was to characterize professional fulfillment through job, career, and specialty satisfaction scores among interventional radiologists using a validated assessment tool.

Results: There were 106 respondents included in the analysis: 97 (91.5%) practicing interventional radiologists and 9 (8.5%) interventional radiology trainees, including 87 (82.1%) males and 19 (17.9%) females. Respondents included those in academic (40; 37.7%), private practice (46; 43.4%), and hybrid/other settings (20; 18.9%), as well as at various lengths of practice. The mean job satisfaction score was 3.48, with 38 (35.8%) of respondents expressing a mean score of ≥ 4, which has been established as being "satisfied". The mean career satisfaction score was 3.40, with 38 (35.8%) of respondents reporting a mean score of ≥ 4. The mean global specialty satisfaction was 3.63 with 53 (50.0%) of respondents reporting a mean score of ≥ 4.

Conclusions: Professional fulfillment is low among interventional radiologists, with half expressing global specialty satisfaction and with minority percentages signaling job and career satisfaction. Patient interaction and work-life balance were identified as significant factors positively affecting professional fulfillment.

背景:有几项分析表明,全科医生的成就感和满意度急剧下降。其他研究表明,职业倦怠、焦虑和道德伤害在介入放射科医生中尤为普遍,然而,关于该职业职业实现的文献很少。本研究的目的是利用一种有效的评估工具,通过工作、职业和专业满意度评分来描述介入放射科医生的专业成就感。结果:共纳入调查对象106人,其中执业放射医师97人(91.5%),实习放射医师9人(8.5%),其中男性87人(82.1%),女性19人(17.9%)。受访者包括那些在学术(40;37.7%),私人执业(46;43.4%)和混合/其他设置(20;18.9%),以及在不同长度的实践。平均工作满意度得分为3.48分,其中38人(35.8%)的平均得分≥4分,为“满意”。平均职业满意度为3.40分,其中38名(35.8%)受访者的平均得分≥4分。全球平均专业满意度为3.63,53名(50.0%)受访者报告平均得分≥4。结论:介入放射科医师的专业满意度较低,半数表示整体专业满意度,少数百分比表示工作和职业满意度。患者互动和工作生活平衡是影响职业成就感的显著因素。
{"title":"Professional fulfillment in interventional radiology.","authors":"Lindsay Eysenbach, Mark Loper, Gabe Li, David S Shin, Eric J Monroe, Matthew Abad-Santos, Eunjee Lee, Hyeonjeong Lim, Anthony Hage, Jeffrey Forris Beecham Chick, Mina S Makary","doi":"10.1186/s42155-025-00588-1","DOIUrl":"10.1186/s42155-025-00588-1","url":null,"abstract":"<p><strong>Background: </strong>There have been several analyses conducted demonstrating a sharp decrease in general physician fulfillment and satisfaction. Other studies have demonstrated that burnout, anxiety, and moral injury are prevalent among interventional radiologists specifically, however there is a paucity of literature examining professional fulfillment within the profession. The purpose of this study was to characterize professional fulfillment through job, career, and specialty satisfaction scores among interventional radiologists using a validated assessment tool.</p><p><strong>Results: </strong>There were 106 respondents included in the analysis: 97 (91.5%) practicing interventional radiologists and 9 (8.5%) interventional radiology trainees, including 87 (82.1%) males and 19 (17.9%) females. Respondents included those in academic (40; 37.7%), private practice (46; 43.4%), and hybrid/other settings (20; 18.9%), as well as at various lengths of practice. The mean job satisfaction score was 3.48, with 38 (35.8%) of respondents expressing a mean score of ≥ 4, which has been established as being \"satisfied\". The mean career satisfaction score was 3.40, with 38 (35.8%) of respondents reporting a mean score of ≥ 4. The mean global specialty satisfaction was 3.63 with 53 (50.0%) of respondents reporting a mean score of ≥ 4.</p><p><strong>Conclusions: </strong>Professional fulfillment is low among interventional radiologists, with half expressing global specialty satisfaction and with minority percentages signaling job and career satisfaction. Patient interaction and work-life balance were identified as significant factors positively affecting professional fulfillment.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"99"},"PeriodicalIF":1.5,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12596238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145471996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
N-butyl cyanoacrylate glue application in prostate artery embolization for benign prostatic hyperplasia: a systematic review of safety and efficacy. 氰基丙烯酸丁酯胶在前列腺动脉栓塞治疗良性前列腺增生中的应用:安全性和有效性的系统评价。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-04 DOI: 10.1186/s42155-025-00616-0
Nawaf Salah Ayad Mohamed, Eman El Khatib, Almamoon I Justaniah, Mohamed E M Fouad, Romaric Loffroy

Background: Benign prostatic hyperplasia (BPH) is the most common urological disorder in older males, often treated with prostate artery embolization (PAE) to alleviate lower urinary tract symptoms. While traditional embolic materials like microspheres are common, issues such as symptom recurrence and non-target embolization remain. This systematic review evaluates the safety and effectiveness of n-butyl cyanoacrylate (NBCA) glue as an alternative embolic agent for PAE.

Materials and methods: A thorough search was performed across databases including PubMed, ScienceDirect, Cochrane, Google Scholar, Scopus, and MEDLINE. Studies were included if they assessed NBCA glue for PAE in BPH patients. Exclusions were made for reviews, non-English articles, conference abstracts, and studies not using glue or ethiodized oil mixtures. The Methodological Index for Non-Randomized Studies criteria was used to assess bias risk, and due to varied outcome measures, a narrative synthesis was conducted.

Results: Six studies involving 667 patients met the inclusion criteria. The age in mean ± SD across studies ranged from 67.5 ± 7.8 to 72.6 ± 10.5 with most patients presenting with moderate to severe BPH unresponsive to medication. NBCA glue-based procedures showed high technical success rates and shorter procedure times. International Prostate Symptom Score improvement was reported in 83-94% of patients across all studies with associated quality of life significantly enhanced in up to 94% of patients as well. Prostate volume reduction ranged from 11% to 40.5%, depending on follow-up duration. PSA levels and medication use decreased, and erectile function was mostly preserved, though results varied. Minor complications like groin hematomas and post-embolization syndrome occurred in 4-22% of patients, with no major adverse events reported.

Conclusion: This review assesses NBCA-based glue as a potential embolic agent in PAE for BPH. The evidence suggests promising short-term outcomes with a favorable safety profile, though findings remain preliminary due to small sample sizes and short follow-up. Larger multicenter randomized trials are therefore needed to validate these results and guide clinical practice.

背景:良性前列腺增生(BPH)是老年男性最常见的泌尿系统疾病,通常采用前列腺动脉栓塞(PAE)治疗以缓解下尿路症状。虽然传统的栓塞材料如微球是常见的,但诸如症状复发和非靶栓塞等问题仍然存在。本系统综述评价了氰基丙烯酸酯正丁酯(NBCA)胶作为PAE栓塞剂的安全性和有效性。材料和方法:在PubMed、ScienceDirect、Cochrane、谷歌Scholar、Scopus和MEDLINE等数据库中进行了彻底的搜索。如果评估NBCA胶对BPH患者PAE的作用,则纳入研究。排除综述、非英文文章、会议摘要和未使用胶水或硫化油混合物的研究。采用非随机研究的方法学指数(Methodological Index for non - random Studies)标准来评估偏倚风险,由于结果测量的差异,我们进行了叙述性综合。结果:6项研究667例患者符合纳入标准。所有研究的平均±SD年龄范围为67.5±7.8至72.6±10.5,大多数患者表现为中度至重度BPH,对药物无反应。NBCA胶基手术技术成功率高,手术时间短。在所有研究中,83-94%的患者报告了国际前列腺症状评分的改善,高达94%的患者的相关生活质量也显著提高。前列腺体积减少范围从11%到40.5%,取决于随访时间。PSA水平和药物使用下降,勃起功能基本保留,尽管结果各不相同。4-22%的患者出现腹股沟血肿和栓塞后综合征等轻微并发症,无重大不良事件报道。结论:本综述评估了nbca基胶作为BPH患者PAE的潜在栓塞剂。尽管由于样本量小、随访时间短,研究结果仍处于初步阶段,但有证据表明,该药物具有良好的短期疗效和良好的安全性。因此,需要更大规模的多中心随机试验来验证这些结果并指导临床实践。
{"title":"N-butyl cyanoacrylate glue application in prostate artery embolization for benign prostatic hyperplasia: a systematic review of safety and efficacy.","authors":"Nawaf Salah Ayad Mohamed, Eman El Khatib, Almamoon I Justaniah, Mohamed E M Fouad, Romaric Loffroy","doi":"10.1186/s42155-025-00616-0","DOIUrl":"10.1186/s42155-025-00616-0","url":null,"abstract":"<p><strong>Background: </strong>Benign prostatic hyperplasia (BPH) is the most common urological disorder in older males, often treated with prostate artery embolization (PAE) to alleviate lower urinary tract symptoms. While traditional embolic materials like microspheres are common, issues such as symptom recurrence and non-target embolization remain. This systematic review evaluates the safety and effectiveness of n-butyl cyanoacrylate (NBCA) glue as an alternative embolic agent for PAE.</p><p><strong>Materials and methods: </strong>A thorough search was performed across databases including PubMed, ScienceDirect, Cochrane, Google Scholar, Scopus, and MEDLINE. Studies were included if they assessed NBCA glue for PAE in BPH patients. Exclusions were made for reviews, non-English articles, conference abstracts, and studies not using glue or ethiodized oil mixtures. The Methodological Index for Non-Randomized Studies criteria was used to assess bias risk, and due to varied outcome measures, a narrative synthesis was conducted.</p><p><strong>Results: </strong>Six studies involving 667 patients met the inclusion criteria. The age in mean ± SD across studies ranged from 67.5 ± 7.8 to 72.6 ± 10.5 with most patients presenting with moderate to severe BPH unresponsive to medication. NBCA glue-based procedures showed high technical success rates and shorter procedure times. International Prostate Symptom Score improvement was reported in 83-94% of patients across all studies with associated quality of life significantly enhanced in up to 94% of patients as well. Prostate volume reduction ranged from 11% to 40.5%, depending on follow-up duration. PSA levels and medication use decreased, and erectile function was mostly preserved, though results varied. Minor complications like groin hematomas and post-embolization syndrome occurred in 4-22% of patients, with no major adverse events reported.</p><p><strong>Conclusion: </strong>This review assesses NBCA-based glue as a potential embolic agent in PAE for BPH. The evidence suggests promising short-term outcomes with a favorable safety profile, though findings remain preliminary due to small sample sizes and short follow-up. Larger multicenter randomized trials are therefore needed to validate these results and guide clinical practice.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"98"},"PeriodicalIF":1.5,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12586764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical utility of artificial intelligence models in radiology: a systemic scoping review of diagnostic and endovascular applications. 人工智能模型在放射学中的临床应用:诊断和血管内应用的系统范围审查。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-30 DOI: 10.1186/s42155-025-00573-8
Som P Singh, Aarya Ramprasad, Mina S Makary

Background: To systematically scope the clinical integration of artificial intelligence (AI) in diagnostic and interventional radiology. This integration encompasses various components of AI forms such as deep learning, convolutional neural networks, natural language processing, and machine learning.

Methodology: A Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews (PRISMA-ScR) was employed to evaluate current primary and translation literature on the utility of AI in diagnostic and interventional radiology in broad disease categories.

Results: Following the review for inclusion criteria, a total of 23 peer-reviewed research articles were selected for review. Notably, most studies were found to focus on diagnostic and interventional radiology and oncologic diseases, including lung, hepatocellular, colorectal, prostate, pancreatic, breast, and blood cancers.

Conclusions: Radiologists have an advantageous role with the integration of these tools in clinical practice. This may include disease prediction models, catheter navigation, and image reconstruction. Utilization of these AI tools can help improve and further expose of the capabilities of diagnostic and interventional radiology to patients worldwide. From a disease standpoint, this review found most of the clinical literature has implemented AI tools for diagnostic and interventional radiology in oncology, followed by vascular diseases. Careful navigation is necessary to address the current logistical challenges, educational demands, and ethical dilemmas to ensure the safe and effective incorporation of these technologies into clinical radiologic settings.

目的:系统地探讨人工智能(AI)在诊断和介入放射学中的临床应用。这种整合包括人工智能形式的各种组成部分,如深度学习、卷积神经网络、自然语言处理和机器学习。方法:采用系统评价和荟萃分析扩展范围评价(PRISMA-ScR)的首选报告项目来评估当前关于人工智能在广泛疾病类别的诊断和介入放射学中的应用的主要和翻译文献。结果:根据纳入标准的审查,共选择23篇同行评议的研究文章进行审查。值得注意的是,大多数研究都集中在诊断和介入放射学和肿瘤学疾病上,包括肺癌、肝细胞癌、结肠直肠癌、前列腺癌、胰腺癌、乳腺癌和血癌。结论:结合这些工具,放射科医师在临床实践中具有优势作用。这可能包括疾病预测模型、导管导航和图像重建。利用这些人工智能工具可以帮助改善并进一步向世界各地的患者展示诊断和介入放射学的能力。从疾病的角度来看,本综述发现大多数临床文献已将人工智能工具用于肿瘤诊断和介入放射学,其次是血管疾病。谨慎的导航是必要的,以解决当前的后勤挑战,教育需求和伦理困境,以确保安全有效地将这些技术纳入临床放射环境。
{"title":"Clinical utility of artificial intelligence models in radiology: a systemic scoping review of diagnostic and endovascular applications.","authors":"Som P Singh, Aarya Ramprasad, Mina S Makary","doi":"10.1186/s42155-025-00573-8","DOIUrl":"10.1186/s42155-025-00573-8","url":null,"abstract":"<p><strong>Background: </strong>To systematically scope the clinical integration of artificial intelligence (AI) in diagnostic and interventional radiology. This integration encompasses various components of AI forms such as deep learning, convolutional neural networks, natural language processing, and machine learning.</p><p><strong>Methodology: </strong>A Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews (PRISMA-ScR) was employed to evaluate current primary and translation literature on the utility of AI in diagnostic and interventional radiology in broad disease categories.</p><p><strong>Results: </strong>Following the review for inclusion criteria, a total of 23 peer-reviewed research articles were selected for review. Notably, most studies were found to focus on diagnostic and interventional radiology and oncologic diseases, including lung, hepatocellular, colorectal, prostate, pancreatic, breast, and blood cancers.</p><p><strong>Conclusions: </strong>Radiologists have an advantageous role with the integration of these tools in clinical practice. This may include disease prediction models, catheter navigation, and image reconstruction. Utilization of these AI tools can help improve and further expose of the capabilities of diagnostic and interventional radiology to patients worldwide. From a disease standpoint, this review found most of the clinical literature has implemented AI tools for diagnostic and interventional radiology in oncology, followed by vascular diseases. Careful navigation is necessary to address the current logistical challenges, educational demands, and ethical dilemmas to ensure the safe and effective incorporation of these technologies into clinical radiologic settings.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"97"},"PeriodicalIF":1.5,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12572426/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145402863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular techniques for the treatment of true renal arterial aneurysms-procedural insights and outcomes. 血管内技术治疗真肾动脉动脉瘤的手术观察和结果。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-30 DOI: 10.1186/s42155-025-00611-5
Arjan Singh Khattar, Raj Das, Joo-Young Chun, Akos Berczi, Lakshmi Ratnam, Seyed Ameli Renani, Ben Hawthorn, Michael Gonsalves, Robert Morgan

Purpose: To discuss endovascular techniques and report the outcomes for endovascular treatment of true renal arterial aneurysms (TRAAs).

Materials and methods: A 22-year retrospective analysis of endovascular treatment of TRAAs in our institution. Aneurysm characteristics and endovascular techniques are discussed. Outcome measures were technical and clinical success (need for reintervention), renal parenchymal perfusion loss, impact on renal function, and complications. A 30-day mortality analysis was performed. Impact on renal function was assessed with a two-tailed, paired t-test of pre- and post-procedural serum creatinine.

Results: Eighteen endovascular procedures were performed to treat 15 TRAAs in 14 patients (including three reinterventions). 14/15 TRAAs were classified as Type 2 and 1/15 as Type 1 (Rundback classification). Mean initial aneurysm size was 22.9 mm (range 5-40 mm). Of the 14 Type 2 TRAAs, five were initially treated with balloon-assisted Onyx embolisation, four with stent-assisted coiling, four with sac packing, and one with stent-grafting. The technical success rate was 100%. The TRAAs requiring reintervention had been originally treated with balloon-assisted Onyx embolisation (two TRAAs) and stent-grafting (one TRAA). Renal parenchymal loss was < 10% in 10/15 TRAAs after initial intervention. At reintervention, 2/3 cases had 60-70% estimated parenchymal loss as the TRAAs had to be treated more aggressively. Complications (grade 1-3) occurred in 5/18 procedures. The grade 2 complication was atrophy and loss of renal function of the treated kidney (with serum creatinine remaining in the normal range) (n = 1). Grade 3 complications were brachial access pseudoaneurysm (n = 1), common femoral vein thrombosis (n = 1), and access site cellulitis (n = 1).

Conclusion: Endovascular treatment of TRAAs has a high rate of technical success and a low impact on renal function. A higher rate of reintervention was observed for TRAAs treated with Onyx embolisation, leading to a shift towards stent-assisted coiling as our preferred technique when anatomically feasible.

目的:探讨血管内治疗真肾动脉动脉瘤(TRAAs)的技术及疗效。材料与方法:回顾性分析我院22年血管内治疗traa的情况。讨论了动脉瘤的特点和血管内技术。结局指标包括技术和临床成功(再次干预的需要)、肾实质灌注损失、对肾功能的影响和并发症。进行30天死亡率分析。对肾功能的影响通过术前和术后血清肌酐的双尾配对t检验进行评估。结果:14例患者共行18次血管内手术治疗15例traa(包括3次再干预)。14/15 traa分类为2型,1/15 traa分类为1型(Rundback分类)。平均初始动脉瘤大小为22.9 mm(范围5-40 mm)。在14例2型traa中,5例最初采用球囊辅助的Onyx栓塞治疗,4例采用支架辅助卷曲治疗,4例采用囊填料治疗,1例采用支架移植治疗。技术成功率100%。需要再干预的TRAA最初采用球囊辅助的Onyx栓塞(2个TRAA)和支架移植(1个TRAA)治疗。结论:血管内治疗TRAAs技术成功率高,对肾功能影响小。采用玛瑙栓塞治疗traa的再介入率较高,因此在解剖学可行的情况下,支架辅助盘绕成为我们的首选技术。
{"title":"Endovascular techniques for the treatment of true renal arterial aneurysms-procedural insights and outcomes.","authors":"Arjan Singh Khattar, Raj Das, Joo-Young Chun, Akos Berczi, Lakshmi Ratnam, Seyed Ameli Renani, Ben Hawthorn, Michael Gonsalves, Robert Morgan","doi":"10.1186/s42155-025-00611-5","DOIUrl":"10.1186/s42155-025-00611-5","url":null,"abstract":"<p><strong>Purpose: </strong>To discuss endovascular techniques and report the outcomes for endovascular treatment of true renal arterial aneurysms (TRAAs).</p><p><strong>Materials and methods: </strong>A 22-year retrospective analysis of endovascular treatment of TRAAs in our institution. Aneurysm characteristics and endovascular techniques are discussed. Outcome measures were technical and clinical success (need for reintervention), renal parenchymal perfusion loss, impact on renal function, and complications. A 30-day mortality analysis was performed. Impact on renal function was assessed with a two-tailed, paired t-test of pre- and post-procedural serum creatinine.</p><p><strong>Results: </strong>Eighteen endovascular procedures were performed to treat 15 TRAAs in 14 patients (including three reinterventions). 14/15 TRAAs were classified as Type 2 and 1/15 as Type 1 (Rundback classification). Mean initial aneurysm size was 22.9 mm (range 5-40 mm). Of the 14 Type 2 TRAAs, five were initially treated with balloon-assisted Onyx embolisation, four with stent-assisted coiling, four with sac packing, and one with stent-grafting. The technical success rate was 100%. The TRAAs requiring reintervention had been originally treated with balloon-assisted Onyx embolisation (two TRAAs) and stent-grafting (one TRAA). Renal parenchymal loss was < 10% in 10/15 TRAAs after initial intervention. At reintervention, 2/3 cases had 60-70% estimated parenchymal loss as the TRAAs had to be treated more aggressively. Complications (grade 1-3) occurred in 5/18 procedures. The grade 2 complication was atrophy and loss of renal function of the treated kidney (with serum creatinine remaining in the normal range) (n = 1). Grade 3 complications were brachial access pseudoaneurysm (n = 1), common femoral vein thrombosis (n = 1), and access site cellulitis (n = 1).</p><p><strong>Conclusion: </strong>Endovascular treatment of TRAAs has a high rate of technical success and a low impact on renal function. A higher rate of reintervention was observed for TRAAs treated with Onyx embolisation, leading to a shift towards stent-assisted coiling as our preferred technique when anatomically feasible.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"96"},"PeriodicalIF":1.5,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12572580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145402887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occult meningo-pial anastomosis, an under-recognized risk of non-target embolization in middle meningeal artery embolization for chronic subdural haematoma. 慢性硬膜下血肿的脑膜中动脉栓塞治疗中,隐蔽性脑膜-脑膜吻合是一种未被认识到的非靶栓塞风险。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-28 DOI: 10.1186/s42155-025-00618-y
Wan Lung Ryo Yeung, Kevan Juan Sham, Wai Lun Poon
{"title":"Occult meningo-pial anastomosis, an under-recognized risk of non-target embolization in middle meningeal artery embolization for chronic subdural haematoma.","authors":"Wan Lung Ryo Yeung, Kevan Juan Sham, Wai Lun Poon","doi":"10.1186/s42155-025-00618-y","DOIUrl":"10.1186/s42155-025-00618-y","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"91"},"PeriodicalIF":1.5,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12559508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of restenosis after drug-coated balloon angioplasty for femoropopliteal chronic total occlusion lesions. 药物包被球囊血管成形术治疗股腘慢性全闭塞病变后再狭窄的预测因素。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-28 DOI: 10.1186/s42155-025-00612-4
Yuki Shima, Mihoko Sato, Gakuto Bando, Narumi Irie, Kazunori Mushiake, Naoya Inoue, Hiroyuki Tanaka, Kazushige Kadota

Background: Drug-coated balloons (DCBs) are widely used in endovascular therapy. While dissection angle and minimum lumen area (MLA) assessed by intravascular ultrasound (IVUS) are known predictors of restenosis, their specific role after DCB angioplasty remains to be fully elucidated. We aimed to identify predictors of restenosis following DCB angioplasty using IVUS findings.

Methods: We retrospectively enrolled 36 peripheral artery disease patients undergoing DCB angioplasty (Jan 2021-Dec 2023). We evaluated IVUS images post-guidewire and post-DCB at 3-cm intervals, classifying cross-sections by MLA/external elastic membrane area (EEMA) ratio: > 50%, 40%-50%, and < 40%. Primary patency at 1 year post-DCB was the primary outcome. Restenosis was objectively determined by a peak systolic velocity ratio of 2.4 on duplex ultrasound, and assessing each cross-sectional images.

Results: A total of 262 cross-sectional images were acquired and subsequently classified into three distinct groups based on their MLA/EEMA ratio: > 50% (n = 125), 40%-50% (n = 85), and < 40% (n = 52). All guidewires passed through the intraplaque route. Primary patency was significantly higher in the MLA/EEMA > 50% group (94.0% vs. 84.2% vs. 73.3%, log-rank p = 0.005). Specifically, for dissection angles > 60°, patency was markedly better in the MLA/EEMA > 50% group (93.3% vs. 75.0% vs. 55.6%, log-rank p = 0.03). Dissection angles < 60° showed no significant patency differences (93.9% vs. 88.0% vs. 84.2%, log-rank p = 0.14).

Conclusions: The MLA/EEMA ratio and the degree of dissection angle may be predictors of primary patency following DCB angioplasty. These findings suggest that optimized vessel preparation strategies can effectively mitigate the adverse clinical impact of dissection.

背景:药物包被球囊(DCBs)广泛应用于血管内治疗。虽然血管内超声(IVUS)评估的夹层角度和最小管腔面积(MLA)是已知的再狭窄的预测因素,但它们在DCB血管成形术后的具体作用仍有待充分阐明。我们的目的是利用IVUS结果确定DCB血管成形术后再狭窄的预测因素。方法:我们回顾性招募36例接受DCB血管成形术的外周动脉疾病患者(2021年1月- 2023年12月)。我们对导丝后和dcb后的IVUS图像进行了3 cm间隔的评估,并根据MLA/外弹性膜面积(EEMA)的比例对截面进行了分类:> 50%,40%-50%。结果:共获得262张横截面图像,并根据MLA/EEMA的比例将其分为> 50% (n = 125), 40%-50% (n = 85)和50%组(94.0% vs. 84.2% vs. 73.3%, log-rank p = 0.005)。具体来说,对于夹层角度bbb60°,MLA/EEMA > 50%组的通畅度明显更好(93.3% vs. 75.0% vs. 55.6%, log-rank p = 0.03)。结论:MLA/EEMA比值和夹层角度可作为DCB血管成形术后原发性通畅的预测指标。这些结果表明,优化血管制备策略可以有效减轻夹层的不良临床影响。
{"title":"Predictors of restenosis after drug-coated balloon angioplasty for femoropopliteal chronic total occlusion lesions.","authors":"Yuki Shima, Mihoko Sato, Gakuto Bando, Narumi Irie, Kazunori Mushiake, Naoya Inoue, Hiroyuki Tanaka, Kazushige Kadota","doi":"10.1186/s42155-025-00612-4","DOIUrl":"10.1186/s42155-025-00612-4","url":null,"abstract":"<p><strong>Background: </strong>Drug-coated balloons (DCBs) are widely used in endovascular therapy. While dissection angle and minimum lumen area (MLA) assessed by intravascular ultrasound (IVUS) are known predictors of restenosis, their specific role after DCB angioplasty remains to be fully elucidated. We aimed to identify predictors of restenosis following DCB angioplasty using IVUS findings.</p><p><strong>Methods: </strong>We retrospectively enrolled 36 peripheral artery disease patients undergoing DCB angioplasty (Jan 2021-Dec 2023). We evaluated IVUS images post-guidewire and post-DCB at 3-cm intervals, classifying cross-sections by MLA/external elastic membrane area (EEMA) ratio: > 50%, 40%-50%, and < 40%. Primary patency at 1 year post-DCB was the primary outcome. Restenosis was objectively determined by a peak systolic velocity ratio of 2.4 on duplex ultrasound, and assessing each cross-sectional images.</p><p><strong>Results: </strong>A total of 262 cross-sectional images were acquired and subsequently classified into three distinct groups based on their MLA/EEMA ratio: > 50% (n = 125), 40%-50% (n = 85), and < 40% (n = 52). All guidewires passed through the intraplaque route. Primary patency was significantly higher in the MLA/EEMA > 50% group (94.0% vs. 84.2% vs. 73.3%, log-rank p = 0.005). Specifically, for dissection angles > 60°, patency was markedly better in the MLA/EEMA > 50% group (93.3% vs. 75.0% vs. 55.6%, log-rank p = 0.03). Dissection angles < 60° showed no significant patency differences (93.9% vs. 88.0% vs. 84.2%, log-rank p = 0.14).</p><p><strong>Conclusions: </strong>The MLA/EEMA ratio and the degree of dissection angle may be predictors of primary patency following DCB angioplasty. These findings suggest that optimized vessel preparation strategies can effectively mitigate the adverse clinical impact of dissection.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"92"},"PeriodicalIF":1.5,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12559451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipiodol marking for CT-guided radiofrequency ablation of adrenal aldosterone-producing adenomas: a case series. ct引导下射频消融肾上腺醛固酮生成腺瘤的脂醇标记:一个病例系列。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-28 DOI: 10.1186/s42155-025-00614-2
Hiromitsu Tannai, Sota Oguro, Hiroyuki Sakakibara, Yumi Nakajima, Hiroki Kamada, Yuta Tezuka, Yoshikiyo Ono, Hideki Ota, Kei Takase

Background: Tumor visualization during computed tomography (CT)-guided radiofrequency ablation (RFA) of adrenal adenomas is often limited by the small size of the lesion and needle-induced artifacts. These limitations can impair accurate needle placement and increase the risk of incomplete ablation. This report shows four adrenal RFA procedures in which iodized oil (Lipiodol®) marking enhanced lesion visibility.

Case presentation: CT imaging and adrenal venous sampling showed unilateral right aldosterone-producing adenomas measuring 10-20 mm in patients with primary aldosteronism. Contrast enhancement of the nodules was confirmed via CT angiography after microcatheter insertion into the adrenal artery. Transarterial embolization was performed utilizing a 1:1 mixture of Lipiodol and iohexol. In three cases, Lipiodol deposition within the adenomas was confirmed on CT immediately post-embolization and persisted on the following day. Despite needle-induced artifacts during RFA, nodule visibility significantly improved. RFA was completed without major complications, which resulted in the resolution of primary aldosteronism and hypertension. In one case, although Lipiodol marking was discontinued due to the extravasation from the adrenal artery branch, RFA was completed on the following day.

Conclusions: CT-guided RFA with Lipiodol marking facilitated the effective treatment of aldosterone-producing adrenal adenomas in three patients by significantly enhancing lesion visibility. Adrenal arterial embolization should be addressed with caution to avoid damaging the small blood vessels of the adrenal gland.

背景:在计算机断层扫描(CT)引导下射频消融术(RFA)治疗肾上腺腺瘤时,肿瘤的可视化常常受到病灶小和针诱发伪影的限制。这些限制会影响针的准确放置,增加消融不完全的风险。本报告显示四例肾上腺RFA手术中碘化油(Lipiodol®)标记增强病变可见性。病例表现:原发性醛固酮增多症患者的CT成像和肾上腺静脉取样显示单侧右侧醛固酮分泌腺瘤,直径10- 20mm。微导管插入肾上腺动脉后,经CT血管造影证实结节增强。经动脉栓塞使用1:1的混合物脂醇和碘己醇。在3例中,栓塞后立即在CT上证实了腺瘤内的脂醇沉积,并持续到第二天。尽管RFA期间针头引起的假影,但结节的可见性显著提高。RFA完成后无重大并发症,导致原发性醛固酮增多症和高血压的解决。在一个病例中,虽然由于肾上腺动脉分支外渗而停止了脂醇标记,但RFA在第二天完成。结论:ct引导下Lipiodol标记的RFA治疗3例醛固酮产生性肾上腺腺瘤,显著提高病灶的可见性,促进了其有效治疗。肾上腺动脉栓塞应谨慎处理,以避免损伤肾上腺的小血管。
{"title":"Lipiodol marking for CT-guided radiofrequency ablation of adrenal aldosterone-producing adenomas: a case series.","authors":"Hiromitsu Tannai, Sota Oguro, Hiroyuki Sakakibara, Yumi Nakajima, Hiroki Kamada, Yuta Tezuka, Yoshikiyo Ono, Hideki Ota, Kei Takase","doi":"10.1186/s42155-025-00614-2","DOIUrl":"10.1186/s42155-025-00614-2","url":null,"abstract":"<p><strong>Background: </strong>Tumor visualization during computed tomography (CT)-guided radiofrequency ablation (RFA) of adrenal adenomas is often limited by the small size of the lesion and needle-induced artifacts. These limitations can impair accurate needle placement and increase the risk of incomplete ablation. This report shows four adrenal RFA procedures in which iodized oil (Lipiodol®) marking enhanced lesion visibility.</p><p><strong>Case presentation: </strong>CT imaging and adrenal venous sampling showed unilateral right aldosterone-producing adenomas measuring 10-20 mm in patients with primary aldosteronism. Contrast enhancement of the nodules was confirmed via CT angiography after microcatheter insertion into the adrenal artery. Transarterial embolization was performed utilizing a 1:1 mixture of Lipiodol and iohexol. In three cases, Lipiodol deposition within the adenomas was confirmed on CT immediately post-embolization and persisted on the following day. Despite needle-induced artifacts during RFA, nodule visibility significantly improved. RFA was completed without major complications, which resulted in the resolution of primary aldosteronism and hypertension. In one case, although Lipiodol marking was discontinued due to the extravasation from the adrenal artery branch, RFA was completed on the following day.</p><p><strong>Conclusions: </strong>CT-guided RFA with Lipiodol marking facilitated the effective treatment of aldosterone-producing adrenal adenomas in three patients by significantly enhancing lesion visibility. Adrenal arterial embolization should be addressed with caution to avoid damaging the small blood vessels of the adrenal gland.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"95"},"PeriodicalIF":1.5,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12569250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Underreporting of inferior vena cava filter characteristics in diagnostic radiology reports: a call for standardization. 在诊断放射学报告中漏报下腔静脉过滤器特征:要求标准化。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-28 DOI: 10.1186/s42155-025-00576-5
Gavin Wu, David S Shin, Neha Naidoo, Spencer B Lewis, Jeffrey Forris Beecham Chick, Eric J Monroe, Anthony N Hage, Mina S Makary
{"title":"Underreporting of inferior vena cava filter characteristics in diagnostic radiology reports: a call for standardization.","authors":"Gavin Wu, David S Shin, Neha Naidoo, Spencer B Lewis, Jeffrey Forris Beecham Chick, Eric J Monroe, Anthony N Hage, Mina S Makary","doi":"10.1186/s42155-025-00576-5","DOIUrl":"10.1186/s42155-025-00576-5","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"93"},"PeriodicalIF":1.5,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12569234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
CVIR Endovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1